Filing metadata

Accession number
0001415889-25-014913
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
May 29, 2025
Reporting period
May 27, 2025
Description
Insider transaction

Explore SEC Filings Hub